Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19

被引：0
|
作者：
Lv, Xiu-He [1 ,2 ]
Yang, Jin-Lin [1 ,2 ]
Deng, Kai [1 ,2 ,3 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Sichuan Univ Oxford Univ Huaxi Gastrointestinal C, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, COVID 19 Med Team Hubei, Chengdu, Sichuan, Peoples R China
[4] Wuhan Univ, Renmin Hosp, East Branch, COVID 19 Med Team Hubei,West China Hosp, Wuhan, Hubei, Peoples R China
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷 / 05期
关键词：
LOPINAVIR/RITONAVIR;
D O I：
10.14309/ajg.0000000000001043
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1099 / 1099
页数：1
相关论文
共 50 条
  • [31] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Yaseen M. Arabi
    Anthony C. Gordon
    Lennie P. G. Derde
    Alistair D. Nichol
    Srinivas Murthy
    Farah Al Beidh
    Djillali Annane
    Lolowa Al Swaidan
    Abi Beane
    Richard Beasley
    Lindsay R. Berry
    Zahra Bhimani
    Marc J. M. Bonten
    Charlotte A. Bradbury
    Frank M. Brunkhorst
    Meredith Buxton
    Adrian Buzgau
    Allen Cheng
    Menno De Jong
    Michelle A. Detry
    Eamon J. Duffy
    Lise J. Estcourt
    Mark Fitzgerald
    Rob Fowler
    Timothy D. Girard
    Ewan C. Goligher
    Herman Goossens
    Rashan Haniffa
    Alisa M. Higgins
    Thomas E. Hills
    Christopher M. Horvat
    David T. Huang
    Andrew J. King
    Francois Lamontagne
    Patrick R. Lawler
    Roger Lewis
    Kelsey Linstrum
    Edward Litton
    Elizabeth Lorenzi
    Salim Malakouti
    Daniel F. McAuley
    Anna McGlothlin
    Shay Mcguinness
    Bryan J. McVerry
    Stephanie K. Montgomery
    Susan C. Morpeth
    Paul R. Mouncey
    Katrina Orr
    Rachael Parke
    Jane C. Parker
    Intensive Care Medicine, 2021, 47 : 867 - 886
  • [32] In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement
    Yang, Philip
    Tekwani, Seema
    Martin, Greg S.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (12) : JC63 - JC63
  • [33] Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir
    Yin, Guosheng
    Zhang, Chenyang
    Jin, Huaqing
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (03): : 231 - 241
  • [34] A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
    Maciorowski, Dawid
    Idrissi, Samir Z. El
    Gupta, Yash
    Medernach, Brian J.
    Burns, Michael B.
    Becker, Daniel P.
    Durvasula, Ravi
    Kempaiah, Prakasha
    SLAS DISCOVERY, 2020, 25 (10) : 1108 - 1122
  • [35] Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
    Horby, Peter W.
    Landray, Martin J.
    Mafham, Marion
    Bell, Jennifer L.
    Linsell, Louise
    Staplin, Natalie
    Emberson, Jonathan R.
    Palfreeman, Adrian
    Raw, Jason
    Elmahi, Einas
    Prudon, Benjamin
    Green, Christopher
    Carley, Simon
    Chadwick, David
    Davies, Matthew
    Wise, Matthew P.
    Baillie, J. Kenneth
    Chappell, Lucy C.
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Lim, Wei Shen
    Montgomery, Alan
    Rowan, Kathryn
    Juszczak, Edmund
    Haynes, Richard
    LANCET, 2020, 396 (10259): : 1345 - 1352
  • [36] Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19
    Shree, Venkatesan
    Liew, Lydia Qi En
    Teo, Wei Wei
    Ting, Jeanette
    Liew, Mei Fong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (01) : 133 - 135
  • [37] Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients
    Chouchana, Laurent
    Boujaafar, Sana
    Gana, Ines
    Preta, Laure-Helene
    Regard, Lucile
    Legendre, Paul
    Azoulay, Celia
    Canoui, Etienne
    Zerbit, Jeremie
    Carlier, Nicolas
    Terrier, Benjamin
    Kerneis, Solen
    Batista, Rui
    Treluyer, Jean-Marc
    Zheng, Yi
    Benaboud, Sihem
    THERAPEUTIC DRUG MONITORING, 2021, 43 (01) : 131 - 135
  • [38] Lopinavir/ritonavir delays COVID-19 recovery in paediatric patients
    Reactions Weekly, 2022, 1903 (1) : 8 - 8
  • [39] SARS-CoV-2 viral dynamics and population pharmacokinetics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19
    Agyeman, Akosua A.
    Brown, Li-An K.
    Guerra-Assuncao, Jose A.
    Breuer, Judy
    Lowe, David M.
    Standing, Joseph F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 291 - 294
  • [40] Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
    Pulido, Federico
    Arribas, Jose R.
    Delgado, Rafael
    Cabrero, Esther
    Gonzalez-Garcia, Juan
    Perez-Elias, Maria J.
    Arranz, Alberto
    Portilla, Joaquin
    Pasquau, Juan
    Iribarren, Jose A.
    Rubio, Rafael
    Norton, Michael
    AIDS, 2008, 22 (02) : F1 - F9
12345